BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31956052)

  • 41. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
    Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M
    J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
    van Velzen M; Missotten T; van Loenen FB; Meesters RJ; Luider TM; Baarsma GS; Osterhaus AD; Verjans GM
    J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor.
    Schneider SM; Pritchard SM; Wudiri GA; Trammell CE; Nicola AV
    mBio; 2019 May; 10(3):. PubMed ID: 31088925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections.
    Prichard MN; Kern ER; Hartline CB; Lanier ER; Quenelle DC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4728-34. PubMed ID: 21788472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice.
    Bhutta MS; Sausen DG; Reed KM; Gallo ES; Hair PS; Lassiter BP; Krishna NK; Cunnion KM; Borenstein R
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sulfonated (1 → 6)-β-d-Glucan (Lasiodiplodan): A Promising Candidate against the Acyclovir-Resistant Herpes Simplex Virus Type 1 (HSV-1) Strain.
    Wouk J; Celestino GG; Rodrigues BCD; Malfatti CRM; Cunha MAA; Orsato A; Barbosa-Dekker AM; Dekker RFH; Lonni AASG; Reis Tavares E; Faccin-Galhardi LC
    Biomacromolecules; 2022 Oct; 23(10):4041-4052. PubMed ID: 36173245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modifications on the heterocyclic base of ganciclovir, penciclovir, acyclovir - syntheses and antiviral properties.
    Chuchkov K; Chayrov R; Hinkov A; Todorov D; Shishkova K; Stankova IG
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(7):979-990. PubMed ID: 32312162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antiviral activity of mangiferin against herpes simplex virus type 2 in vitro].
    Zhu XM; Song JX; Huang ZZ; Wu YM; Yu MJ
    Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):452-4. PubMed ID: 8010041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo activity of eugenol on human herpesvirus.
    Benencia F; Courrèges MC
    Phytother Res; 2000 Nov; 14(7):495-500. PubMed ID: 11054837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Herpes simplex virus-1 entrapped in Candida albicans biofilm displays decreased sensitivity to antivirals and UVA1 laser treatment.
    Ascione C; Sala A; Mazaheri-Tehrani E; Paulone S; Palmieri B; Blasi E; Cermelli C
    Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):72. PubMed ID: 29137671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lupeol impairs herpes simplex virus type 1 replication by inhibiting the promoter activity of the viral immediate early gene α0.
    Ye J; Wang Z; Jia J; Li F; Wang Y; Jiang Y; Wang Y; Ren Z; Pu H
    Acta Virol; 2021; 65(3):254-263. PubMed ID: 34565153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.
    Strand M; Islam K; Edlund K; Oberg CT; Allard A; Bergström T; Mei YF; Elofsson M; Wadell G
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5735-43. PubMed ID: 22908173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
    Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
    Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
    Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
    Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic effects of acyclovir and 3, 19-isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains.
    Priengprom T; Ekalaksananan T; Kongyingyoes B; Suebsasana S; Aromdee C; Pientong C
    BMC Complement Altern Med; 2015 Mar; 15():56. PubMed ID: 25879785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infection.
    Bridges CG; Ahmed SP; Sunkara PS; McCarthy JR; Tyms AS
    Antiviral Res; 1995 Aug; 27(4):325-34. PubMed ID: 8540753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.
    Kesharwani A; Polachira SK; Nair R; Agarwal A; Mishra NN; Gupta SK
    BMC Complement Altern Med; 2017 Feb; 17(1):110. PubMed ID: 28196487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ellagitannins as synergists of ACV on the replication of ACV-resistant strains of HSV 1 and 2.
    Vilhelmova-Ilieva N; Jacquet R; Quideau S; Galabov AS
    Antiviral Res; 2014 Oct; 110():104-14. PubMed ID: 25111906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay.
    Sauerbrei A; Vödisch S; Bohn K; Schacke M; Gronowitz S
    J Virol Methods; 2013 Mar; 188(1-2):70-2. PubMed ID: 23246510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.